Beacon Equity Issues Technical Trade Alerts on Drug Manufacturers: JNJ, ABT, LLY, PFE, NVS, GSK

DALLAS, Feb. 18  /PRNewswire/ -- BeaconEquity.com announces the availability of Trade Alerts on stocks making news today.

Investors can view all of the daily trading notes for free by visiting: http://www.beaconequity.com/m

Today's Trade Alerts include: Johnson & Johnson (NYSE:JNJ), Abbott Laboratories (NYSE:ABT), Eli Lilly & Co. (NYSE:LLY), Pfizer Inc. (NYSE: PFE), Novartis AG (NYSE:NVS) and GlaxoSmithKline plc (NYSE:GSK).

Join the fastest growing investment community at: http://www.stockhideout.com/

See what Cramer has to say about these stocks at: http://maddmoney.net/

BeaconEquity.com's Trade Alerts are brief analyses on the active stocks each day that are affecting the markets. These include breaking news, insider activity, recent 52-week highs/lows, technical breakouts, and other market driving information. Beacon is the authority on research in the small cap sector, and our analysts strive each day to find the stocks that are poised to be the biggest movers before the rest of the market is aware of them.

We encourage investors to subscribe to our FREE newsletter filled with daily trading ideas by visiting: http://www.beaconequity.com/m

BeaconEquity.com is one of the industry's largest small cap research providers. Beacon strives to provide a balanced view of many promising small cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the publicly available information available on them. For more information on Beacon Research, please visit: http://www.beaconequity.com/m CRD# 2207572.

BeaconEquity.com Disclosure

BeaconEquity.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BeaconEquity.com is a wholly owned entity of BlueWave Advisors, LLC, a financial public relations firm. Please read our report and visit our website, BeaconEquity.com, for complete risks and disclosures.

  Beacon Equity Research
  Jeff Bishop, (469)-252-3505
  



David C. Masson of Beacon Equity Research is a member of the National Association of Securities Dealers, CRD number 2207572.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

JEFF BISHOP

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=70781 

DATASOURCE: BeaconEquity.com



CONTACT:  Jeff Bishop of Beacon Equity Research, [phone],





Web Site:  http://www.beaconequityresearch.com/ 

Copyright